In Mali, improved traditional medicines [“Médicaments
Traditionnels Améliorés”] are prepared from
traditionally used medicinal plants. Recently, the Department of Traditional
Medicine has identified Terminalia macroptera Guill. & Perr.
(Combretaceae) as a potential candidate for an improved traditional
medicine. T. macroptera is a West African medicinal plant used in
Mali against various health disorders, with more than 30 different
indications mentioned by traditional healers, including hepatitis,
gonorrhea, fever, pain relief, and various infectious diseases
(Helicobacter pylori-associated diseases). To date, validation of
most of the biological activities of has been mainly carried out in
vitro, except for antimalarial activities. In this study, the
potential anti-inflammatory, antipyretic, analgesic, and hepatoprotective
properties of T. macroptera were investigated in different murine
models. Administration of T. macroptera ethanolic root and leaf
extracts in rats significantly reduced pyrexia, pain, inflammation, and
hepatic marker enzymes such as alanine aminotransferase, aspartate
aminotransferase, and alkaline phosphatase in the different murine models
used (p<0.05). A phytochemical screening of T. macroptera
revealed the presence of tannins, flavonoids, saponins, anthracene
derivatives, sterols, triterpenes, and sugars in both leaf and root extracts
as the main phytochemical compounds. This was confirmed by qualitative
analysis, liquid chromatography coupled with high-resolution mass
spectrometry. T. macroptera extracts demonstrated interesting in
vivo antipyretic, analgesic, anti-inflammatory, and hepatoprotective
activities. Therefore, T. macroptera should be proposed and further
evaluated as a potential improved traditional medicine for the treatment of
liver-related disorders and for the relief of pain and fever.